Minjun Du
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 9
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 3
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Yushun Gao (14 shared papers)Yanjiao Zhang (2 shared papers)Jun Zhao (1 shared paper)Jinfeng Huang (1 shared paper)Yousheng Mao (1 shared paper)Dali Wang (1 shared paper)Shugeng Gao (1 shared paper)Qi Xue (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Journal of Cellular and Molecular Medicine (2 papers)The Thoracic and Cardiovascular Surgeon (1 paper)Frontiers in Immunology (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Minjun Du
15 papers receiving 312 citations
Peers
Comparison fields: 5 of 38
- Cancer Research 218
- Molecular Biology 275
- Pulmonary and Respiratory Medicine 31
- Oncology 25
- Immunology 13
Countries citing papers authored by Minjun Du
This map shows the geographic impact of Minjun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minjun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minjun Du more than expected).
Fields of papers citing papers by Minjun Du
This network shows the impact of papers produced by Minjun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minjun Du. The network helps show where Minjun Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Minjun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 161 | |
| 2 | miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1. | 2015 | 57 |
| 3 | 2020 | 21 | |
| 4 | 2020 | 18 | |
| 5 | 2021 | 9 | |
| 6 | 2021 | 9 | |
| 7 | 2022 | 8 | |
| 8 | 2022 | 7 | |
| 9 | 2023 | 6 | |
| 10 | 2024 | 5 | |
| 11 | 2020 | 4 | |
| 12 | 2017 | 3 | |
| 13 | 2017 | 3 | |
| 14 | 2019 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2024 | 0 | |
| 18 | 2017 | 0 |
About Minjun Du
Minjun Du is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Surgery, having authored 18 papers that have together received 313 indexed citations. Recurring topics across this work include RNA modifications and cancer (9 papers), Cancer-related molecular mechanisms research (6 papers), Ferroptosis and cancer prognosis (4 papers), Epigenetics and DNA Methylation (4 papers), MicroRNA in disease regulation (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Circular RNAs in diseases (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (218 citations), Molecular Biology (275 citations), Pulmonary and Respiratory Medicine (31 citations), Oncology (25 citations) and Immunology (13 citations). Minjun Du has collaborated with scholars based in China and United States. Frequent co-authors include Yushun Gao, Yanjiao Zhang, Jun Zhao, Jinfeng Huang, Yousheng Mao, Dali Wang, Shugeng Gao, Qi Xue, Dali Wang and Qi Xue. Their work appears in journals such as Frontiers in Oncology, Journal of Cellular and Molecular Medicine, The Thoracic and Cardiovascular Surgeon, Frontiers in Immunology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.